Senior Fellow in Science and Technology Policy
Nonresident Scholar
By Kirstin R.W. Matthews, Omar Kawam, Keri Sprung, Emerson C. Perin and Zubin Master
The intense marketing of unproven stem cell interventions (SCIs) has become an international health concern, and relying on government regulators to shut down unscrupulous clinics is no longer an option.1 Physicians are typically excellent resources when patients have questions about various medical therapies. Because many SCIs have not been approved for use, specialists are unlikely to raise the topic with patients, and other physicians may not be fully prepared to discuss them. Our goal is to describe how individuals are targeted, suggest educational resources, and offer physicians ideas regarding effective counseling.
Read the full article in the Texas Heart Institute Journal.
